Pharmaceutical composition for modified release

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12097189
SERIAL NO

18613281

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4′-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a maximum blood drug concentration (Cmax) when administered in fasted state is 400 ng/ml or less, is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASTELLAS PHARMA INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Murayama, Daisuke Tokyo, JP 80 203
Murayama, Emiko Tokyo, JP 7 18
Nakamura, Soichiro Tokyo, JP 23 311
Nishizato, Takashi Tokyo, JP 8 41
Sako, Kazuhiro Tokyo, JP 33 924
Takahashi, Yutaka Tokyo, JP 230 4433
Takaishi, Yuuki Tokyo, JP 29 237

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 24, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 24, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 24, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00